日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab deruxtecan efficacy in patients with HER2-positive gastric cancer

肿瘤内HER2异质性对HER2阳性胃癌患者曲妥珠单抗疗效的临床影响

期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-026-01736-9
Yoshino, Koichiro; Takamatsu, Manabu; Ooki, Akira; Chin, Keisho; Takahari, Daisuke; Osumi, Hiroki; Ogura, Mariko; Tamba, Mikako; Fukuda, Koshiro; Shimozaki, Keitaro; Udagawa, Shohei; Fukuoka, Shota; Shinozaki, Eiji; Yamaguchi, Kensei; Wakatsuki, Takeru
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer

基于拷贝数的癌基因优势可能提示 HER2 阳性胃癌中 ERBB2 依赖性和曲妥珠单抗反应

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-026-01204-5
Wakatsuki, Takeru; Yamamoto, Noriko; Ishizuka, Naoki; Hironaka, Shuichi; Minashi, Keiko; Kadowaki, Shigenori; Hirano, Hidekazu; Shoji, Hirokazu; Yamaguchi, Toshifumi; Chin, Keisho; Ogura, Mariko; Nakayama, Izuma; Osumi, Hiroki; Ueki, Arisa; Kitano, Shigehisa; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke
胃癌
肿瘤
HER2
肿瘤免疫
ERBB2
发表日期：2026
文献求助 收藏

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer

药房门诊随访对维持接受CAPOX辅助化疗的胃癌患者相对剂量强度的重要性

期刊:Molecular and Clinical Oncology
影响因子:1.4
doi:10.3892/mco.2026.2943
Nakamura, Masashi; Yokokawa, Takashi; Kawakami, Kazuyoshi; Kimura, Yuka; Shimizu, Hisanori; Kobayashi, Kazuo; Aoyama, Takeshi; Suzuki, Wataru; Hatori, Masahiro; Suzuki, Kenichi; Takahari, Daisuke; Ogura, Mariko; Chin, Keisho; Wakatsuki, Takeru; Yamaguchi, Kensei; Yamaguchi, Masakazu
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Increased treatment options and improved survival in real-world patients with HER2-positive advanced gastric cancer from 2011 to 2023

2011年至2023年，HER2阳性晚期胃癌患者的真实世界治疗选择增加，生存率提高。

期刊:
影响因子:
doi:10.1177/17562848261441026
Shimozaki, Keitaro; Ooki, Akira; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

在无法切除的局部晚期食管鳞状细胞癌患者中，接受根治性放化疗后使用阿特珠单抗治疗——一项多中心 2 期试验 (EPOC1802)

期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-025-00918-1
Bando Hideaki, Kumagai Shogo, Kotani Daisuke, Mishima Saori, Irie Takuma, Itahashi Kota, Tanaka Yosuke, Habu Takumi, Fukaya Sayuri, Kondo Masaki, Tsushima Takahiro, Hara Hiroki, Kadowaki Shigenori, Kato Ken, Chin Keisho, Yamaguchi Kensei, Kageyama Shun-Ichiro, Hojo Hidehiro, Nakamura Masaki, Tachibana Hidenobu, Wakabayashi Masashi, Fukui Makoto, Fuse Nozomu, Koyama Shohei, Mano Hiroyuki, Nishikawa Hiroyoshi, Shitara Kohei, Yoshino Takayuki, Kojima Takashi
细胞生物学
发表日期：2025
文献求助 收藏

Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

调查免疫疗法在2011年至2023年间对HER2阴性晚期胃癌患者的真实世界治疗中的作用

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251322670
Shimozaki, Keitaro; Ooki, Akira; Yoshino, Koichiro; Tamba, Mikako; Udagawa, Shohei; Osumi, Hiroki; Fukuoka, Shota; Nakayama, Izuma; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Shinozaki, Eiji; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
HER2
免疫/内分泌
发表日期：2025
文献求助 收藏

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

循环肿瘤DNA在HER2阳性晚期胃癌中的临床意义：一项双重HER2和PD-1靶向治疗Ib期试验的合作研究（Ni-High）

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251367344
Osumi, Hiroki; Wakatsuki, Takeru; Ooki, Akira; Chin, Keisho; Shoji, Hirokazu; Ogura, Mariko; Nakayama, Izuma; Yamamoto, Noriko; Hirano, Hidekazu; Hara, Hiroki; Minashi, Keiko; Shinozaki, Eiji; Kato, Ken; Ishizuka, Naoki; Kitano, Shigehisa; Takeuchi, Kengo; Boku, Narikazu; Yamaguchi, Kensei; Takahari, Daisuke
胃癌
肿瘤
HER2
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial

局部晚期食管鳞状细胞癌患者新辅助化疗和手术后辅助使用S-1的II期试验：PIECE试验

期刊:Annals of Surgical Oncology
影响因子:3.5
doi:10.1245/s10434-024-16325-2
Nomura, Motoo; Yamaguchi, Toshifumi; Chin, Keisho; Hato, Shinji; Kato, Ken; Baba, Eishi; Matsubara, Hisahiro; Mukaida, Hidenori; Yoshii, Takako; Tsuda, Masahiro; Tsubosa, Yasuhiro; Kitagawa, Yuko; Oze, Isao; Ishikawa, Hideki; Muto, Manabu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma

新辅助多西他赛、顺铂和5-氟尿嘧啶治疗局部晚期食管鳞状细胞癌的真实世界安全性和有效性

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14011-4
Tamba, Mikako; Osumi, Hiroki; Ogura, Mariko; Fukuoka, Shota; Okamura, Akihiko; Kanamori, Jun; Imamura, Yu; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Watanabe, Masayuki; Yamaguchi, Kensei; Chin, Keisho; Ooki, Akira
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Safety and efficacy of zolbetuximab plus chemotherapy for claudin 18 isoform 2-positive advanced gastric cancer: initial report of real-world experience

佐贝妥昔单抗联合化疗治疗 Claudin 18 同工型 2 阳性晚期胃癌的安全性和有效性：真实世界经验的初步报告

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06406-4
Shimozaki, Keitaro; Ooki, Akira; Fukuoka, Shota; Osumi, Hiroki; Yoshikawa, Kaoru; Yoshino, Koichiro; Udagawa, Shohei; Wakatsuki, Takeru; Shinozaki, Eiji; Ogura, Mariko; Chin, Keisho; Yamaguchi, Kensei
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏